Cao Shengli's scientific research achievements

1. Wang; Zhang, male; Cao; Lin, H.H. Gao, male; Synthesis of 1- substituted 4( 1H)- quinazolinone without solvent. Synth。 Commun.20 1 1,doi: 10. 1080/003979 1 1.20 1 1.566407。

2. Cao; Zhao; Zhang; Wang; Jiang, Yan Yang; Synthesis and crystal structure of 4-(3- nitropyridine -2- amino) phenol and 4-(3- aminopyridine -2- amino) phenol. Doctor of chemistry. crystal ogr . 20 1 1,4 1, 1456- 1460。

3. Cao; Wang; Zhu; Liao; Guo, Yu Wei; Chen; Liu; Xu, synthesis and cytotoxicity of x. N-((2- methyl -4(3H)- quinazolinone -6- yl) methyl) dithiocarbamate, Europe. Doctor of medicine. Chemistry. 20 10, 45, 3850-3857.

4. Cao; Guo, Yu Wei; Wang; Zhang, male; Feng; Jiang, Yan Yang; Wang; High, q; Synthesis and cytotoxicity screening of piperazine-1- 0-dithiocarbamate derivatives of 2- substituted quinazolin -4(3H)- one, Arch. Pharmaceutical industry. 2009, 342, 182- 189.

5. Cao; Zhang, male; Feng; Jiang, Yan Yang; Zhang, N. Synthesis of 3- aryl -4(3H)- quinazolinone from o-aminobenzoic acid and triethyl orthoformate, Synth .Commun.2008, 38, 2227-2236.

6. Cao; Feng; Zheng; Jiang, Yan Yang; Zhang, male; Wang; Synthesis and cytotoxicity of substituted-benzylamino-and heterocyclic methylamino-dithiocarbamate derivatives of 4(3H)- quinazolinone, Arch. Pharmaceutical industry. 2006,339,250-254.

7. Cao Shaolin, Feng, Yang Ping, Jiang Yuying, Liu Shiying, Ding Guiying, Li Ruitao, Synthesis and in vitro antitumor activity of 4(3H)- quinazolinone derivatives containing dithiocarbamate side chains, Acta Biologica. Medicine. Chemistry. Letter 2005, 15,1915-1917.

8. Cao Shaolin, Wan, Feng, Yang Ping, A new synthetic method and synthesis of thymidylate synthase inhibitor retitraxel. Commun.2003,33,3519-35261.,Xu Xingzhi, Liao Ji, Han Ying, Zhao, Liu,,,, 4- quinazolinone -6- methylaminodithiocarbamate and its pharmaceutical composition and application, application number: 20/.

2. Cao Shengli, 4- quinazolinone derivative and its application in antineoplastic drugs, patent number ZL 2005 1056 18.5, authorization announcement date: 2008. 1 19.

3. Cao Shengli, synthetic process of anti-cancer drug raltitrexed, patent number ZL 0213 1 091.2, date of authorization announcement: August 3, 20051.

4. Piperazine dithiocarbamate derivative of 2,4-diaminoquinazoline, Xu Xingzhi, Liao Ji, Han Ying, Zhao, its preparation method and anti-tumor application, application number: 20110257528.3, general project of National Natural Science Foundation, science and technology plan of Beijing Education Commission. He has published more than 70 papers in domestic and foreign academic journals such as EUR. Doctor of medicine. Chemistry. Brewer. Medicine. Chemistry. Ritter. , arch. Pharmaceutical industry. And Synth Commun。 In recent years, he applied for four invention patents.